Release Summary

ANTIBE THERAPEUTICS ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBER AND PROVIDES UPDATE ON PHASE 2 TRIAL OF ATB-346

Antibe Therapeutics Inc.